Skip to main content

Yesterday, March 16, 2016, 100 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $51.12 to $7,757,838.42.

Highlighted Stocks Traded by Insiders:

BRT Realty (BRT) - FREE Research Report

Gould Investors L P, who is 10% Owner at BRT Realty, bought 1,532 shares at $6.64 on March 16, 2016. Following this transaction, the 10% Owner owned 3.0 million shares meaning that the stake was boosted by 0.05% with the 1,532-share transaction.

The shares most recently traded at $6.73, up $0.09, or 1.34% since the insider transaction. Historical insider transactions for BRT Realty go as follows:

  • 4-Week # shares bought: 78,512
  • 4-Week # shares sold: 1,850
  • 12-Week # shares bought: 78,512
  • 12-Week # shares sold: 1,850
  • 24-Week # shares bought: 78,512
  • 24-Week # shares sold: 1,850

The average volume for BRT Realty has been 13,200 shares per day over the past 30 days. BRT Realty has a market cap of $94.1 million and is part of the financial sector and real estate industry. Shares are up 5.52% year-to-date as of the close of trading on Wednesday.

BRT Realty Trust, a real estate investment trust (REIT), owns, operates, and develops multi-family properties in the United States. It operates through two segments, Multi-Family Real Estate and Other Real Estate. Currently, there are no analysts who rate BRT Realty a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BRT - FREE

TheStreet Quant Ratings

rates BRT Realty as a

TheStreet Recommends

sell

. The company's weaknesses can be seen in multiple areas, such as its poor profit margins, weak operating cash flow and generally disappointing historical performance in the stock itself. Get the full

BRT Realty Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Biomarin Pharmaceutical (BMRN) - FREE Research Report

Davis George Eric, who is EVP, General Counsel at Biomarin Pharmaceutical, sold 1,996 shares at $86.21 on March 16, 2016. Following this transaction, the EVP, General Counsel owned 76,190 shares meaning that the stake was reduced by 2.55% with the 1,996-share transaction.

The shares most recently traded at $77.80, down $8.41, or 10.81% since the insider transaction. Historical insider transactions for Biomarin Pharmaceutical go as follows:

  • 4-Week # shares sold: 15,878
  • 12-Week # shares sold: 15,878
  • 24-Week # shares sold: 17,240

The average volume for Biomarin Pharmaceutical has been 1.8 million shares per day over the past 30 days. Biomarin Pharmaceutical has a market cap of $13.5 billion and is part of the health care sector and drugs industry. Shares are down 23.31% year-to-date as of the close of trading on Wednesday.

BioMarin Pharmaceutical Inc. develops and commercializes pharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. Currently, there are 13 analysts who rate Biomarin Pharmaceutical a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BMRN - FREE

TheStreet Quant Ratings

rates Biomarin Pharmaceutical as a

sell

. The company's weaknesses can be seen in multiple areas, such as its generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. Get the full

Biomarin Pharmaceutical Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

CSG Systems International (CSGS) - FREE Research Report

Smith Donald V, who is Director at CSG Systems International, sold 10,000 shares at $39.23 on March 16, 2016. Following this transaction, the Director owned 32,868 shares meaning that the stake was reduced by 23.33% with the 10,000-share transaction.

The shares most recently traded at $41.91, up $2.68, or 6.38% since the insider transaction. Historical insider transactions for CSG Systems International go as follows:

  • 4-Week # shares sold: 4,214
  • 12-Week # shares sold: 4,214
  • 24-Week # shares sold: 82,700

The average volume for CSG Systems International has been 425,000 shares per day over the past 30 days. CSG Systems International has a market cap of $1.3 billion and is part of the technology sector and computer software & services industry. Shares are up 12.34% year-to-date as of the close of trading on Wednesday.

CSG Systems International, Inc. provides business support solutions primarily to the communications industry. The stock currently has a dividend yield of 1.88%. The company has a P/E ratio of 21.1. Currently, there is 1 analyst who rates CSG Systems International a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on CSGS - FREE

TheStreet Quant Ratings

rates CSG Systems International as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full

CSG Systems International Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.